Tumor Ablation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Tumor Ablation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Market Overview:

The global tumor ablation market size reached US$ 1,050 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,110 Million by 2028, exhibiting a growth rate (CAGR) of 12.3% during 2023-2028.

Tumor ablation refers to a minimally invasive (MI) technique that is conducted to treat tumors of the kidney, liver, bones and lungs. The ablation system consists of a generator and a needlelike device that delivers the heat directly to the target cells to cause acute cellular necrosis. The procedure destroys benign tumors by inserting a probe and heating it to 100-degree Celsius under Precise Computer Tomography, without extracting them from the body. It can be conducted through Microwave Ablation, Radiofrequency Ablation, Cryoablation, etc. It provides increased accuracy and covers a larger treatment area, along with minimal pain and risk to the patient upon repeated administrations.

The increasing prevalence of cancer is one of the key factors driving the growth of the market. Furthermore, owing to benefits such as the lesser amount of trauma, speedy recovery, reduced complications and shorter hospital stay, MI procedures are gaining widespread preference, which, in turn, is driving the market growth. Also, various technological advancements such as the introduction of thermal and laser ablation, irreversible electroporation and High-Intensity Focused Ultrasound (HIFU) have enhanced the acceptance of tumor ablation procedures. Moreover, the implementation of favorable government policies for cancer awareness and treatment methods is also creating a positive outlook for the market. Other factors driving the market include growing healthcare expenditures and rising geriatric population, along with the increasing number of ablation and surgical centers and awareness for ablation procedures that can be conducted over small tumors.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global tumor ablation market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on technology, mode of treatment, mode of application and end-user.

Breakup by Technology:

Radiofrequency (RF) Ablation
Microwave Ablation
Cryoablation
Others

Breakup by Mode of Treatment:

Percutaneous Ablation
Laparoscopic Ablation
Surgical Ablation

Breakup by Mode of Application:

Liver Cancer
Lung Cancer
Kidney Cancer
Bone Metastasis
Others

Breakup by End-User:

Hospitals
Cancer Specialty Clinics
Others

Breakup by Region:


North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Medtronic Public Limited Company, AngioDynamics, Inc., HealthTronics, Inc., NeuWave Medical, Inc., INTIO, Inc., Galil Medical Ltd., Boston Scientific Corporation, SonaCare Medical, LLC, EDAP TMS S.A., Erbe Elektromedizin GmbH, IceCure Medical Ltd., MISONIX Inc., Endocare Inc., CooperSurgical Inc. and B V M Meditech Pvt.

Key Questions Answered in This Report

1. What was the size of the global tumor ablation market in 2022?
2. What is the expected growth rate of the global tumor ablation market during 2023-2028?
3. What has been the impact of COVID-19 on the global tumor ablation market?
4. What are the key factors driving the global tumor ablation market?
5. What is the breakup of the global tumor ablation market based on the technology?
6. What is the breakup of the global tumor ablation market based on the mode of treatment?
7. What is the breakup of the global tumor ablation market based on mode of application?
8. What is the breakup of the global tumor ablation market based on the end-user?
9. What are the key regions in the global tumor ablation market?
10. Who are the key players/companies in the global tumor ablation market?